Chordate Medical Holding AB (publ) (STO:CMH)

Market Cap	17.33M
Revenue (ttm)	2.44M
Net Income (ttm)	-27.25M
Shares Out	2.70M
EPS (ttm)	-27.96
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	440
Average Volume	4,249
Open	6.42
Previous Close	6.32
Day's Range	6.42 - 6.86
52-Week Range	4.99 - 48.00
Beta	1.67
RSI	54.37
Earnings Date	May 23, 2025

About STO:CMH

Chordate Medical Holding AB (publ), a medical technology company, engages in the development of products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It offers Ozilia, a neuromodulation and drug-free treatment technology for chronic migraine and chronic rhinitis. The company was founded in 2005 and is based in Kista, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 3
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: CMH

Financial Performance

In 2024, STO:CMH's revenue was 2.44 million, an increase of 39.85% compared to the previous year's 1.75 million. Losses were -27.25 million, -6.62% less than in 2023.